erythromycin has been researched along with Atrial Fibrillation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gomes, T; Huang, A; Juurlink, DN; Macdonald, EM; Mamdani, MM; Quinn, KL | 1 |
| Aonuma, K; Fujii, A; Fujino, T; Hikita, H; Kobori, A; Kuwahara, T; Miyazaki, S; Okubo, K; Sato, A; Takagi, K; Takahashi, A; Takahashi, Y; Takei, A; Takigawa, M; Watari, Y | 1 |
| Cooper, JW; Morton, MR | 1 |
3 other study(ies) available for erythromycin and Atrial Fibrillation
| Article | Year |
|---|---|
Macrolides, Digoxin Toxicity and the Risk of Sudden Death: A Population-Based Study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Atrial Fibrillation; Azithromycin; Cardiotonic Agents; Case-Control Studies; Cefuroxime; Clarithromycin; Death, Sudden; Digoxin; Drug Interactions; Erythromycin; Female; Heart Failure; Humans; Macrolides; Male; Ontario; Risk Factors | 2017 |
Clinical characteristics and management of periesophageal vagal nerve injury complicating left atrial ablation of atrial fibrillation: lessons from eleven cases.
Topics: Anastomosis, Surgical; Anti-Bacterial Agents; Atrial Fibrillation; Catheter Ablation; Chi-Square Distribution; Erythromycin; Esophagus; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Postoperative Complications; Pulmonary Veins; Treatment Outcome; Vagus Nerve Injuries | 2013 |
Erythromycin-induced digoxin toxicity.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Digoxin; Erythromycin; Female; Humans; Myocardial Infarction | 1989 |